Skip to main content

Professor Mark Lawler

Professor in the Centre for Cancer Research and Cell Biology, Chair in Translational Cancer Genomics, Dean of Education in the Faculty of Medicine, Health and Life Sciences

The Patrick G Johnston Centre for Cancer Research

Professor Lawler is passionate about translating high quality science for the benefit of patients and has over 20 years’ experience in cancer research.

Professor Lawler has over 20 years’ experience in cancer research with a significant record of research achievement, having published over 130 peer-reviewed publications and received numerous national and international awards.

He is an experienced contributor to national/international science policy development as chair/member of committees in biomedical science, biotechnology, cancer research, scholar exchange, bioethics, biobanking, cancer care. He was the architect of the European Cancer Patient's Bill of Rights (BoR), a catalyst for change and empowerment tool for cancer patients which launched in the European Parliament on in 2014. The BoR has been adopted across Europe and led to the 70:35 Vision, 70% survival for all cancer patients in Europe by 2035 which was recently adopted by ECCO, the largest interdisciplinary cancer organisation in Europe.

Professor Lawler is also a passionate advocate for the development of outreach activities, fostering increased public understanding of science/medicine.


Cancer Precision medicine
Areas of Expertise

Genetics, Molecular/Experimental Medicine, Cancer biology/medicine, Drug discovery, Graduate education, Bioethics, Science/education policy, Art Therapy, Public perception of Science

Media Experience

Professor Lawler has extensive media experience and has worked with a range of print, broadcast and online media. 

Notable coverage

Associated Research Centres / Projects

Member of the Ethics Review Expert Group DG Research and Innovation, European Commission (EC) and Independent Expert/Evaluator for EC, Health Directorate (Bioethics).

Queen's Lead of the £5M Medical Research Council-Cancer Research UK funded Stratified Medicine in Colorectal Cancer Consortium (S:CORT), a UK-wide consortium investigating novel precision medicine approaches in colorectal cancer(CRC).

Queen's Lead of the Health Data Research UK Substantive Site, one of only six in the UK, which aims to drive innovative precision medicine and public health approaches through the use of Big Data. He is also national lead for Cancer Strategy for HDR-UK.


Contact Information

For more information or to book an interview, email 

Academic Profile
Related Experts